SE:ONCO Stock Latest News
Company AnnouncementsOncopeptides Announces Nomination Committee for 2027 Annual General Meeting4h ago
Company AnnouncementsOncopeptides Earnings Call Signals Stronger Commercial Momentum Ahead5d ago
Company AnnouncementsEU approves Pepaxti label expansion for third-line multiple myeloma1w ago
Company AnnouncementsOncopeptides Reports Strong Pepaxti Growth and Glioblastoma Breakthrough2w ago
Company AnnouncementsEuropean real-world data supports Pepaxti in advanced myeloma2w ago
Company AnnouncementsOncopeptides Boosts Capital Base with Directed Share Issue to Institutional Investors3w agoCompany AnnouncementsOncopeptides Raises SEK 100 Million in Discounted Directed Share Issue to Fund Glioblastoma Push1M ago
Company AnnouncementsOncopeptides Seeks SEK 100m in Directed Share Issue to Accelerate Glioblastoma Program1M ago
Company AnnouncementsOncopeptides to Brief Investors After Positive Glioblastoma Study Data1M ago
Company AnnouncementsOncopeptides Reports Breakthrough Blood-Brain Barrier Data in Glioblastoma Study1M ago
Company AnnouncementsOncopeptides earns EANO poster nod as PDC platform pushes into glioblastoma1M ago
Company AnnouncementsOncopeptides to Present New Pepaxti Data at Key Myeloma Meeting1M agoCompany AnnouncementsOncopeptides Wins EMA Backing to Move Pepaxti Into Third-Line Myeloma Use2M ago
Company AnnouncementsOncopeptides lifts Q2 sales 62% and moves to double Pepaxti market in Europe2M ago
Company AnnouncementsOncopeptides to Present Q2 2026 Results as Oncology Commercialization Expands3M ago
Company AnnouncementsOncopeptides Secures Slovenian List Price for Pepaxti in First CEE Expansion Step3M ago- Company AnnouncementsOncopeptides Updates Share and Vote Structure After Incentive Share Conversion4M ago
Company AnnouncementsOncopeptides Enrolls First Patient in Pioneering Glioblastoma PDC Trial5M ago
Company AnnouncementsOncopeptides seeks EMA approval to move Pepaxti into earlier-line multiple myeloma treatment5M ago
Company AnnouncementsOncopeptides launches German real-world study to bolster Pepaxti’s myeloma profile5M ago

